UDP-glucuronosyltransferase 1A1*6 and *28 polymorphisms as indicators of initial dose level of irinotecan to reduce risk of neutropenia in patients receiving FOLFIRI for colorectal cancer

被引：0
|
作者：
Yoshinori Miyata
Tetsuo Touyama
Takaya Kusumi
Yoshitaka Morita
Nobuyuki Mizunuma
Fumihiro Taniguchi
Mitsuaki Manabe
机构：
[1] Saku Central Hospital Advanced Care Center,Department of Medical Oncology
[2] Nakagami Hospital,Department of Surgery
[3] Keiyukai Sapporo Hospital,Department of Surgery
[4] National Hospital Organization Kobe Medical Center,Department of Radiology
[5] Cancer Institute Hospital of Japanese Foundation for Cancer Research,Department of Gastroenterology
[6] Japanese Red Cross Kyoto Daiichi Hospital,Hepato
[7] Yakult Honsha Co.,Pancreatic Surgery Division
[8] Ltd.,undefined
来源：
International Journal of Clinical Oncology | 2016年 / 21卷
关键词：
Colorectal; Irinotecan; Neutropenia; Polymorphism; UGT1A1 enzyme;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：696 / 703
页数：7
相关论文
共 50 条
  • [21] Associations between UGT1A1*6 or UGT1A1*6/*28 polymorphisms and irinotecan-induced neutropenia in Asian cancer patients
    Fei-fei Han
    Chang-long Guo
    Dan Yu
    Jin Zhu
    Li-li Gong
    Guang-run Li
    Ya-li Lv
    He Liu
    Guang-yu An
    Li-hong Liu
    Cancer Chemotherapy and Pharmacology, 2014, 73 : 779 - 788
  • [22] Associations between UGT1A1*6 or UGT1A1*6/*28 polymorphisms and irinotecan-induced neutropenia in Asian cancer patients
    Han, Fei-fei
    Guo, Chang-long
    Yu, Dan
    Zhu, Jin
    Gong, Li-li
    Li, Guang-run
    Lv, Ya-li
    Liu, He
    An, Guang-yu
    Liu, Li-hong
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2014, 73 (04) : 779 - 788
  • [23] Dose adjustment of irinotecan based on UGT1A1 polymorphisms in patients with colorectal cancer
    Fujii, Hironori
    Yamada, Yunami
    Watanabe, Daichi
    Matsuhashi, Nobuhisa
    Takahashi, Takao
    Yoshida, Kazuhiro
    Suzuki, Akio
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2019, 83 (01) : 123 - 129
  • [24] Dose adjustment of irinotecan based on UGT1A1 polymorphisms in patients with colorectal cancer
    Hironori Fujii
    Yunami Yamada
    Daichi Watanabe
    Nobuhisa Matsuhashi
    Takao Takahashi
    Kazuhiro Yoshida
    Akio Suzuki
    Cancer Chemotherapy and Pharmacology, 2019, 83 : 123 - 129
  • [25] The impact of UGT1A1*28 and UGT1A1*6 on irinotecan-induced neutropenia in Asian cancer patients receiving weekly and three weekly irinotecan regimens
    Chowbay, B.
    Rao, S. J. Srinivasa Jada
    Cher, B. C. Goh Boon
    Lim, R. Robert
    Teck, W. T. Lim Wan
    Huat, E. H. Tan Eng
    EJC SUPPLEMENTS, 2006, 4 (12): : 136 - 136
  • [26] A Phase I Study of UGT1A1*28/*6 Genotype-Directed Dosing of Irinotecan (CPT-11) in Korean Patients with Metastatic Colorectal Cancer Receiving FOLFIRI
    Kim, Kyu-Pyo
    Hong, Yong Sang
    Lee, Jae-Lyun
    Bae, Kyun Seop
    Kim, Ho-Sook
    Shin, Jae-Gook
    Lee, Jung Shin
    Kim, Tae Won
    ONCOLOGY, 2015, 88 (03) : 164 - 172
  • [27] Rapid analysis of UDP-glucuronosyltransferase polymorphisms (UGT1A1*28, UGT1A6*2 and UGT1A7*3) using real-time PCR
    Möhrle, B
    Köhle, C
    Bock, KW
    Schwab, M
    Wernet, D
    Münzel, PA
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2002, 365 : R160 - R160
  • [28] Regorafenib plus FOLFIRI with irinotecan dose escalated according to UGT1A1 genotyping in patients with metastatic colorectal cancer.
    Huang, Chao-Yuan
    Huang, Ching-Wen
    Tsai, Hsiang-Lin
    JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (3_SUPPL) : 125 - 125
  • [29] Cost-effectiveness analysis of UGT1A1*6/*28 genotyping for preventing FOLFIRI-induced severe neutropenia in Chinese colorectal cancer patients
    Wei, XiaoXia
    Cai, JiaQin
    Sun, Hong
    Li, Na
    Xu, Chenxia
    Zhang, Guifeng
    Sui, Yuxia
    Zhuang, Jie
    Zheng, Bin
    PHARMACOGENOMICS, 2019, 20 (04) : 241 - 250
  • [30] Genotype-directed, dose-finding study of irinotecan in cancer patients with UGT1A1☆28 and/or UGT1A1☆6 polymorphisms
    Satoh, Taroh
    Ura, Takashi
    Yamada, Yasuhide
    Yamazaki, Kentaro
    Tsujinaka, Toshimasa
    Munakata, Masaki
    Nishina, Tomohiro
    Okamura, Shu
    Esaki, Taito
    Sasaki, Yasutsuna
    Koizumi, Wasaburo
    Kakeji, Yoshihiro
    Ishizuka, Naoki
    Hyodo, Ichinosuke
    Sakata, Yuh
    CANCER SCIENCE, 2011, 102 (10) : 1868 - 1873
12345